[HTML][HTML] Machine learning models for predicting of PD-1 treatment efficacy in Pan-cancer patients based on routine hematologic and biochemical parameters
W Yang, C Chen, Q Ouyang, R Han… - Cancer Cell …, 2024 - cancerci.biomedcentral.com
Immune checkpoint blockade therapy targeting the programmed death-1 (PD-1) pathway
has shown remarkable efficacy and durable response in patients with various cancer types …
has shown remarkable efficacy and durable response in patients with various cancer types …
Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors
K Kosumi, Y Baba, Y Hara, H Wang, D Nomoto… - Annals of Surgical …, 2024 - Springer
Background Obesity is associated with increased mortality in various cancers, but the
relationship between obesity and clinical outcomes in unresectable or recurrent esophageal …
relationship between obesity and clinical outcomes in unresectable or recurrent esophageal …
A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck …
MY Lien, TZ Hwang, CC Wang, CY Hsieh, CC Yang… - Targeted Oncology, 2024 - Springer
Background Little is known regarding the prognostication of the Pan-Immune-Inflammation
Value (PIV) in patients with recurrent or metastatic head and neck squamous cell carcinoma …
Value (PIV) in patients with recurrent or metastatic head and neck squamous cell carcinoma …
[HTML][HTML] Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous …
J Ajani, F El Hajbi, D Cunningham, M Alsina… - ESMO open, 2024 - Elsevier
Background The phase III RATIONALE-302 study evaluated tislelizumab, an anti-
programmed cell death protein 1 antibody, as second-line (2L) treatment for …
programmed cell death protein 1 antibody, as second-line (2L) treatment for …
[引用][C] Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma
Q Wang, X Meng, X Sun, H Liu - Asian journal of surgery, 2023 - pubmed.ncbi.nlm.nih.gov
Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line
immunotherapy in advanced esophageal squamous cell carcinoma Prognostic significance of …
immunotherapy in advanced esophageal squamous cell carcinoma Prognostic significance of …